Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06610617 · ClinicalTrials.gov registry record · NA

Neuromodulation of Central Sensory Integration to Improve Postural Control

A NA study of Quality of Life and Survivorship, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
48
Enrollment target
1
Study location

NCT06610617 is a NA study of Quality of Life and Survivorship that has completed, run by University of Pittsburgh. The registered enrollment target is 48 participants, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06610617, a NA study of Quality of Life and Survivorship, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
1
Study location

Study Summary

The objective is to evaluate if neuromodulation of the PFC can acutely improve sensory integration for balance performance in OTTBCS.

Interventions

  • DEVICE Sham tDCS
  • DEVICE transcranial direct current stimulation (tDCS)

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2024-10-14
Est. Completion 2025-07-31
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06610617

The ClinicalTrials.gov registry entry for NCT06610617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 107 other Quality of Life trials with a reported enrollment target (89% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Quality of Life appearing as the primary indexed condition, and to 2 interventions - of which Sham tDCS is the first listed.

NCT06610617 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06610617 about?

NCT06610617 is a clinical study titled "Neuromodulation of Central Sensory Integration to Improve Postural Control". The objective is to evaluate if neuromodulation of the PFC can acutely improve sensory integration for balance performance in OTTBCS.

What is the current status of trial NCT06610617?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2024-10-14. Estimated completion is 2025-07-31.

What conditions does trial NCT06610617 study?

This clinical trial studies the following conditions: Quality of Life, Survivorship, Cognitive Deficits, Mild.

What interventions are being tested in trial NCT06610617?

The interventions under investigation include: Sham tDCS (DEVICE), transcranial direct current stimulation (tDCS) (DEVICE).

Who is sponsoring clinical trial NCT06610617?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06610617 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Quality of Life

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.